The timeline of adjuvant and neoadjuvant therapy for melanoma

Bookmark and Share
Published: 23 Sep 2016
Views: 1955
Rating:
Save
Dr Jean Jacques Grob - Hôpital de la Timone, Marseille, France

Dr Grob speaks with ecancertv at WCCS 2016 about the timeline of adjuvant and neoadjuvant therapy for melanoma.

He considers how advances in targeted molecules and immunotherapy could change the progression of treatments for melanoma treatment beyond surgery in the first instance, and how biomarkers could define the most at-risk patient populations.

ecancer's filming at WCCS 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.